Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,535.22
3,374.95
2,935.19
2,702.02
2,204.23
2,407.38
2,133.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,535.22
3,374.95
2,935.19
2,702.02
2,204.23
2,407.38
2,133.33
Raw Material Cost
1,150.05
1,206.16
904.51
1,173.28
921.75
987.66
844.69
Purchase of Finished goods
234.09
456.48
295.94
119.28
198.71
180.32
110.60
(Increase) / Decrease In Stocks
38.36
-181.65
71.34
-66.37
-45.62
-206.70
-79.46
Employee Cost
681.84
639.89
547.88
556.36
489.65
396.45
318.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.02
0.01
-0.01
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
745.31
669.11
653.83
644.85
702.01
572.05
488.18
Total Expenditure (Excl Depreciation)
2,849.63
2,790.00
2,473.49
2,427.40
2,266.50
1,929.78
1,682.47
Operating Profit (PBDIT) excl Other Income
685.59
584.95
461.70
274.62
-62.27
477.60
450.86
Other Income
142.58
46.75
53.24
63.21
45.93
38.38
35.46
Operating Profit (PBDIT)
828.17
631.70
514.94
337.83
-16.34
515.98
486.32
Interest
136.97
198.53
224.72
180.62
127.26
108.46
115.39
Exceptional Items
-20.44
3,280.19
-120.15
8.88
-166.88
44.28
92.42
Gross Profit (PBDT)
670.76
525.25
109.24
147.52
-310.48
451.80
463.35
Depreciation
149.15
143.40
169.14
182.32
172.34
154.43
128.36
Profit Before Tax
521.59
382.79
-72.42
-178.27
-482.82
297.37
334.99
Tax
75.39
56.76
17.99
-62.39
-46.78
20.16
21.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
446.22
325.08
-77.86
27.57
-436.03
277.22
313.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
3,188.11
60.83
18.57
0.00
14.77
-13.59
Net Profit
446.22
3,513.18
-17.03
46.14
-436.03
291.99
299.60
Share in Profit of Associates
-0.98
-1.29
-87.73
-244.68
-67.18
-78.00
-62.45
Minority Interest
-3.96
3.55
24.75
1.28
3.80
2.99
0.04
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
429.25
3,511.27
-88.79
-193.10
-489.43
222.36
240.31
Equity Capital
92.17
92.16
91.89
90.29
89.78
89.63
89.55
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
21.92
9.55
5.42
-8.86
-13.55
4.22
10.48
Operating Profit Margin (Excl OI)
19.39%
17.33%
15.73%
10.16%
-2.83%
19.84%
21.13%
Gross Profit Margin
18.97%
15.56%
3.72%
5.46%
-14.09%
18.77%
21.72%
PAT Margin
12.62%
9.63%
-2.65%
1.02%
-19.78%
11.52%
14.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 4.75% vs 14.98% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is -87.78% vs 4,054.58% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 17.20% vs 26.69% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -31.01% vs -11.65% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Strides Pharma With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
3,535.22
3,201.15
334.07
10.44%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,535.22
3,201.15
334.07
10.44%
Raw Material Cost
1,150.05
1,711.78
-561.73
-32.82%
Purchase of Finished goods
234.09
138.08
96.01
69.53%
(Increase) / Decrease In Stocks
38.36
3.21
35.15
1,095.02%
Employee Cost
681.84
554.79
127.05
22.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.02
-0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
745.31
423.00
322.31
76.20%
Total Expenditure (Excl Depreciation)
2,849.63
2,830.85
18.78
0.66%
Operating Profit (PBDIT) excl Other Income
685.59
370.30
315.29
85.14%
Other Income
142.58
93.43
49.15
52.61%
Operating Profit (PBDIT)
828.17
463.73
364.44
78.59%
Interest
136.97
70.18
66.79
95.17%
Exceptional Items
-20.44
-18.23
-2.21
-12.12%
Gross Profit (PBDT)
670.76
375.32
295.44
78.72%
Depreciation
149.15
114.43
34.72
30.34%
Profit Before Tax
521.59
260.89
260.70
99.93%
Tax
75.39
85.83
-10.44
-12.16%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
446.22
175.05
271.17
154.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
446.22
175.05
271.17
154.91%
Share in Profit of Associates
-0.98
0.00
-0.98
Minority Interest
-3.96
-1.76
-2.20
-125.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
429.25
170.58
258.67
151.64%
Equity Capital
92.17
30.62
61.55
201.01%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
18.97%
11.72%
0.00
7.25%
PAT Margin
12.62%
5.47%
0.00
7.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 3,535.22 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 4.75% vs 14.98% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 429.25 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -87.78% vs 4,054.58% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 685.59 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 17.20% vs 26.69% in Dec 2024
Nine Monthly - Interest
Interest 136.97 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -31.01% vs -11.65% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.39%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
